Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
3.680
+0.020 (0.55%)
At close: Oct 17, 2025, 4:00 PM EDT
3.620
-0.060 (-1.63%)
After-hours: Oct 17, 2025, 5:12 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $14.51 million as of October 17, 2025. Its market cap has decreased by -14.50% in one year.
Market Cap
14.51M
Enterprise Value
-14.53M
1-Year Change
-14.50%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $14.51M, a decrease of -97.04%. That is a compound annual growth rate of -49.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 14.28M | -37.07% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |